首页 › 头颈鳞状细胞癌 › 密苏里州 › Kansas City
Kansas City MO 头颈鳞状细胞癌临床试验
9项针对 头颈鳞状细胞癌的研究正在 Kansas City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
招募中2/3 期
- Site #0149, Westwood · 距离 5 英里
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
招募中3 期
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- 以及另外 1 项
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
招募中观察性研究
- University of Kansas, Westwood · 距离 5 英里
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
招募中2/3 期
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距离 5 英里
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距离 5 英里
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
招募中3 期
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 距离 5 英里
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Saint Luke's Cancer Institute, Kansas City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- The University of Kansas Cancer Center - Westwood, Westwood · 距离 5 英里
- University of Kansas Cancer Center, Westwood · 距离 5 英里
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
招募中3 期
- University of Kansas Cancer Center, Westwood · 距离 5 英里
其他城市的 头颈鳞状细胞癌试验
- Houston, TX47 项研究
- Los Angeles, CA42 项研究
- Boston, MA40 项研究
- New York City, NY39 项研究
- Nashville, TN39 项研究
- St. Louis, MO28 项研究
- Arlington, VA26 项研究
- Chicago, IL26 项研究
- Philadelphia, PA26 项研究
- Atlanta, GA24 项研究
- San Antonio, TX22 项研究
- New Haven, CT22 项研究
Kansas City的其他研究
- 乳腺癌34 项研究
- 非小细胞肺癌31 项研究
- 心力衰竭25 项研究
- 癌症（所有类型）21 项研究
- 肺癌19 项研究
- 结直肠癌16 项研究
- 转移性癌症15 项研究
- 急性髓系白血病15 项研究
- 前列腺癌14 项研究
- 卵巢癌11 项研究
- 肥胖症11 项研究
- 2型糖尿病11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。